Eric Lefkofsky Discusses Data, Genetics and Precision Medicine at Giving Pledge Learning Session

Eric Lefkofsky Discusses Data, Genetics and Precision Medicine at Giving Pledge Learning Session

NEWS

In order to accelerate research and improve the treatment options for patients diagnosed with cancer, Eric Lefkofsky, co-founder and CEO of Tempus, discusses why a data-driven approach must be part of the solution. (February 21, 2017)